Fred Alger Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Fred Alger Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-27,653	Closed	-$1.49M	–	607
2017 Q4	$1.49M	Sell	27,653 -500	-2%	-$27.4K	0.01%	310
2017 Q3	$1.61M	Buy	28,153 +8,000	+40%	+$469K	0.01%	299
2017 Q2	$1.21M	Buy	20,153 +3,618	+22%	+$206K	0.01%	324
2017 Q1	$900K	Buy	+16,535	New	+$814K	﹤0.01%	330

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Fred Alger Management's BIVV Position: Q1 2018 in Review

Fred Alger Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 27,653 shares — an estimated $1.49M sold.

Fred Alger Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.61M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Fred Alger Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Fred Alger Management sold 27,653 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.49M.
Fred Alger Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Fred Alger Management's Bioverativ Inc. Common Stock position peaked at $1.61M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Fred Alger Management's 13F filing for Q1 2018, filed 10 May 2018.